PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly established
joint breast cancer program of the University of Pittsburgh Cancer
Institute and Magee-Womens Hospital. He will also join the University
of Pittsburgh as professor of medicine and epidemiology.
Dr. Vogel comes to Pittsburgh from the University of Texas M.D.
Anderson Cancer Center, where he was responsible for recruiting
the largest number of women onto the Breast Cancer Prevention
Trial, the national study designed to determine the value of tamoxifen
(Nolva-dex) in preventing breast cancer in high-risk women.
"One of the program's most important missions," Dr.
Vogel said, "will be to enhance delivery of care to women
who face barriers, ie, older women or those who are poor or live
in rural areas."